Elevate your local knowledge

Sign up for the iNFOnews newsletter today!

Select Region

Selecting your primary region ensures you get the stories that matter to you first.

Panel: People 65 and older should get a 2nd, different shot against pneumonia-causing bacteria

NEW YORK, N.Y. – A federal panel says older Americans should start getting a new vaccine against bacteria that cause pneumonia.

The Advisory Committee on Immunization Practices voted Wednesday to recommend a dose of the expensive new shot for people 65 and older. The panel said older adults should still get an older pneumococcal vaccine, too.

The newer vaccine — Pfizer’s Prevnar-13 — was licensed in 2011 and costs about $135 per dose. It already is recommended for infants and people with certain medical conditions.

One dose of an older vaccine — which targets a different lineup of bacteria — remained the standard for older adults. A Dutch study this year found Prevnar-13 prevented more pneumonia in the elderly.

Officials believe the new shot could prevent 5,000 illnesses a year.

___

Online:

Panel: http://www.cdc.gov/vaccines/acip

News from © The Associated Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.

Join the Conversation!

Want to share your thoughts, add context, or connect with others in your community?

The Associated Press

The Associated Press is an independent global news organization dedicated to factual reporting. Founded in 1846, AP today remains the most trusted source of fast, accurate, unbiased news in all formats and the essential provider of the technology and services vital to the news business. More than half the world’s population sees AP journalism every day.